Combination of Soy Isoflavones, 8-Prenylnaringenin and Melatonin Improves Hot Flashes and Health-Related Quality of Life Outcomes in Postmenopausal Women: Flavie Study
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: This study aims to investigate the effects of a combination of soy isoflavones, 8-prenylnaringenin (8-PN), and melatonin in postmenopausal women suffering from moderate-to-severe hot flashes (HFs).Methods: A multicenter, prospective, open-label study enrolled 44 postmenopausal women suffering from moderate-to-severe HFs (≥ 5 daily or ≥ 35 weekly) to receive 54.4 mg standardized soy isoflavones (including 24.5 mg genistein and 16.3 mg daidzein), 100 µg 8-PN, and 1 mg melatonin once daily for 12 weeks. The primary clinical outcomes included changes in health-related quality of life (HRQoL) scores (Menopause-Specific QoL questionnaire [MENQoL] and Cervantes Scale) and HFs following 4 and 12 weeks of treatment. Other analyses included treatment adherence, acceptability, tolerability, and safety.Results: All of the four domains of MENQoL questionnaire significantly improved at 4 weeks (P < 0.05) and 12 weeks (P < 0.001), affecting significantly the vasomotor, psychosocial, and physical spheres (41.2%, 26.3%, and 25.0%; 12 weeks improvements, respectively). Similarly, in the menopause (39.3%) and psychic (51.7%) domains (both P < 0.05 at 12 weeks), the global score of the Cervantes Scale significantly increased at 4 weeks (18.6%) and 12 weeks (35.4%). Accordingly, moderate-to-severe HFs significantly decreased at 4 weeks compared to baseline (41.7% reduction) and further reduced at 12 weeks (76.5%), including the total number of episodes.Conclusions: Food supplements containing soy isoflavones, 8-PN, and melatonin showed an early and progressive benefit for reducing clinically significant HFs and for improving HRQoL across all domains, favorably affecting postmenopausal women’s overall well-being.
Abstract
Objectives: This study aims to investigate the effects of a combination of soy isoflavones, 8-prenylnaringenin (8-PN), and melatonin in postmenopausal women suffering from moderate-to-severe hot flashes (HFs).Methods: A multicenter, prospective, open-label study enrolled 44 postmenopausal women suffering from moderate-to-severe HFs (≥ 5 daily or ≥ 35 weekly) to receive 54.4 mg standardized soy isoflavones (including 24.5 mg genistein and 16.3 mg daidzein), 100 µg 8-PN, and 1 mg melatonin once daily for 12 weeks. The primary clinical outcomes included changes in health-related quality of life (HRQoL) scores (Menopause-Specific QoL questionnaire [MENQoL] and Cervantes Scale) and HFs following 4 and 12 weeks of treatment. Other analyses included treatment adherence, acceptability, tolerability, and safety.Results: All of the four domains of MENQoL questionnaire significantly improved at 4 weeks (P < 0.05) and 12 weeks (P < 0.001), affecting significantly the vasomotor, psychosocial, and physical spheres (41.2%, 26.3%, and 25.0%; 12 weeks improvements, respectively). Similarly, in the menopause (39.3%) and psychic (51.7%) domains (both P < 0.05 at 12 weeks), the global score of the Cervantes Scale significantly increased at 4 weeks (18.6%) and 12 weeks (35.4%). Accordingly, moderate-to-severe HFs significantly decreased at 4 weeks compared to baseline (41.7% reduction) and further reduced at 12 weeks (76.5%), including the total number of episodes.Conclusions: Food supplements containing soy isoflavones, 8-PN, and melatonin showed an early and progressive benefit for reducing clinically significant HFs and for improving HRQoL across all domains, favorably affecting postmenopausal women’s overall well-being.
참고문헌 (49)
- Rees M, "The essential menopause curriculum for healthcare professionals : a European Menopause and Andropause Society(EMAS)position statement", Maturitas, 158, pp.70~77 (2022)
- Bansal R, "Menopausal hot flashes : a concise review", J Midlife Health, 10, pp.6~13 (2019)
- Caan B, "Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes : a placebo-controlled randomized trial", Menopause, 22, pp.607~615 (2015)
- Delamater L, "Management of the perimenopause", Clin Obstet Gynecol, 61, pp.419~432 (2018)
- Jenabi E, "Assessment of questionnaire measuring quality of life in menopausal women : a systematic review", Oman Med J, 30, pp.151~156 (2015)
- Bolge SC, "Burden associated with chronic sleep maintenance insomnia characterized by nighttime awakenings among women with menopausal symptoms", Menopause, 17, pp.80~86 (2010)
- The 2022 Hormone Therapy Position Statement of The North American Menopause SocietyAdvisory Panel, "The 2022 hormone therapy position statement of The North American Menopause Society", Menopause, 29, pp.767~794 (2022)
- Hill DA, "Hormone therapy and other treatments for symptoms of menopause", Am Fam Physician, 94, pp.884~889 (2016)
- Parish SJ, "The evolving role of oral hormonal therapies and review of conjugated estrogens", bazedoxifene for the management of menopausal symptoms, 2017, pp.129, 340~351
- North American Menopause Society, "The role of soy isoflavones in menopausal health: report of The North American Menopause Society", Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010), 2011, pp.18, 732~753
- Li L, "Quantitative efficacy of soy isoflavones on menopausal hot flashes", Br J Clin Pharmacol, 79, pp.593~604 (2015)
- Taku K, "Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity : systematic review and meta-analysis of randomized controlled trials", Menopause, 19, pp.776~790 (2012)
- Nahas EA, "Efficacy and safety of a soy isoflavone extract in postmenopausal women : a randomized, double-blind, and placebocontrolled study", Maturitas, 58, pp.249~258 (2007)
- Riesco E, "Effect of exercise combined with phytoestrogens on quality of life in postmenopausal women", Climacteric, 14, pp.573~580 (2011)
- Basaria S, "Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women", J Endocrinol Invest, 32, pp.150~155 (2009)
- Heyerick A, "A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts", Maturitas, 54, pp.164~175 (2006)
- Sehmisch S, "Comparison of the phytohormones genistein, resveratrol and 8-prenylnaringenin as agents for preventing osteoporosis", Planta Med, 74, pp.794~801 (2008)
- Štulíková K, "Therapeutic perspectives of 8-prenylnaringenin, a potent phytoestrogen from hops", Molecules, 23, pp.660~ (2018)
- "Assessment report on Humulus lupulus L., flos" (2014)[URL]
- "Estrogen and estrogen/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms - recommendations for clinical evaluation" (2003)[URL]
- "Assessing and improving measures of hot flashes: summary of an NIH workshop" (2004)[URL]
- Hilditch JR, "A menopause-specific quality of life questionnaire: development and psychometric properties", Maturitas, 24, pp.161~175 (1996)
- Castelo-Branco C, "Understanding how personality factors may influence quality of life : development and validation of the Cervantes Personality Scale", Menopause, 15, pp.914~918 (2008)
- "International scientific guideline:ICH topic E 9 - note for guidance on statistical principles for clinical trials" (1999)[URL]
- D’Anna R, "Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women : a 1-year randomized, double-blind, placebo-controlled study", Menopause, 14, pp.648~655 (2007)
- Coronado PJ, "Predictive and criterion validity of the Cervantes-SF menopause quality of life questionnaire", Menopause, 28, pp.935~942 (2021)
- Whiteley J, "The impact of menopausal symptoms on quality of life, productivity, and economic outcomes", J Womens Health (Larchmt), 22, pp.983~990 (2013)
- Coronado PJ, "Population-based norms for the Cervantes-SF short-form questionnaire assessing health-related quality of life in menopause", Maturitas, 146, pp.34~41 (2021)
- Utian WH, "Impact of hormone therapy on quality of life after menopause", Menopause, 20, pp.1098~1105 (2013)
- Coronado PJ, "Structural validity of a 16-item abridged version of the Cervantes Health-Related Quality of Life scale for menopause : the Cervantes Short-Form Scale", Menopause, 22, pp.325~336 (2015)
- Savolainen-Peltonen H, "Health-related quality of life in women with or without hot flashes : a randomized placebo-controlled trial with hormone therapy", Menopause, 21, pp.732~739 (2014)
- Toffol E, "Melatonin in perimenopausal and postmenopausal women : associations with mood, sleep, climacteric symptoms, and quality of life", Menopause, 21, pp.493~500 (2014)
- Benkherouf AY, "Humulone modulation of GABAA receptors and its role in hops sleep-promoting activity", Front Neurosci, 14, pp.594708~ (2020)
- Shahmohammadi A, "The efficacy of herbal medicines on anxiety and depression in peri-and postmenopausal women : a systematic review and meta-analysis", Post Reprod Health, 25, pp.131~141 (2019)
- Amato P, "Effect of soy isoflavone supplementation on menopausal quality of life", Menopause, 20, pp.443~447 (2013)
- Gómez-Zorita S, "Scientific evidence supporting the beneficial effects of isoflavones on human health", Nutrients, 12, pp.3853~ (2020)
- Evans M, "The effect of synthetic genistein on menopause symptom management in healthy postmenopausal women : a multi-center, randomized, placebo-controlled study", Maturitas, 68, pp.189~196 (2011)
- Lethaby A, "Phytoestrogens for menopausal vasomotor symptoms", Cochrane Database Syst Rev, 2013, pp.CD001395~ (2013)
- "Guideline on clinical investigation of medicinal products for Hormone replacement therapy of oestrogen deficiency symptoms in Post-menopausal women" (2005)[URL]
- Cuadros JL, "Perceived stress, insomnia and related factors in women around the menopause", Maturitas, 72, pp.367~372 (2012)
- Newton KM, "Methods for the design of vasomotor symptom trials : the menopausal strategies : finding lasting answers to symptoms and health network", Menopause, 21, pp.45~58 (2014)
- Chen MN, "Efficacy of phytoestrogens for menopausal symptoms : a meta-analysis and systematic review", Climacteric, 18, pp.260~269 (2015)
- Chen LR, "Isoflavone supplements for menopausal women: a systematic review", Nutrients, 11, pp.2649~ (2019)
- Thomas AJ, "Effects of isoflavones and amino acid therapies for hot flashes and co-occurring symptoms during the menopausal transition and early postmenopause : a systematic review", Maturitas, 78, pp.263~276 (2014)
- López-Ríos L, "Influence of a new botanical combination on quality of life in menopausal Spanish women : results of a randomized, placebo-controlled pilot study", PLoS One, 16, pp.e0255015~ (2021)
- Rattanatantikul T, "Efficacy and safety of nutraceutical on menopausal symptoms in post-menopausal women : a randomized, double-blind, placebocontrolled clinical trial", J Diet Suppl, 19, pp.168~183 (2022)
- Knight DC, "Effects on menopausal symptoms and acceptability of isoflavone-containing soy powder dietary supplementation", Climacteric, 4, pp.13~18 (2001)
- Baber RJ, "Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women", Climacteric, 2, pp.85~92 (1999)
- 강인혜, "Effect of isoflavone supplementation on menopausal symptoms: a systematic review and meta-analysis of randomized controlled trials", Nutrition Research and Practice, 16(3), pp.147~159 (2022), 한국영양학회[DOI]